Showing 19,821 - 19,840 results of 100,886 for search '(( 5 nm decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.54s Refine Results
  1. 19821
  2. 19822
  3. 19823

    LBP RCT dataset. by Mohammad Sidiq (18625406)

    Published 2024
    “…</p><p>Findings</p><p>Post-intervention score comparisons between the groups revealed that the pain education intervention led to a significant reduction in disability compared to the usual standard care at 6 weeks (mean difference 8.2, p < 0.001, effect size Cohen d = 0.75), a decrease in pain intensity (mean difference 3.5, p < 0.001, effect size Cohen d = 0.82), and an improvement in the well-being index (mean difference 13.7, p < 0.001, effect size Cohen d = 0.58).…”
  4. 19824

    ERK5-RNA interference suppresses MCF-7-MEK5 tumor growth and restores ER-α protein expression. by James W. Antoon (444010)

    Published 2013
    “…Decreased expression of ERK5 was confirmed with (A) RT-PCR and (B) western blot analysis. …”
  5. 19825

    Inhibition correlates with cellular PmV levels. by Luca Gambini (826027)

    Published 2015
    “…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
  6. 19826

    Table_1_Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review.DOCX by Vito Terlizzi (5564168)

    Published 2022
    “…No solid data regarding specific SARS-CoV-2 therapies in patients with CF emerged.</p>Conclusion<p>Most people with CF experience a mild course of SARS-CoV-2 infection, nevertheless subgroups with higher risk of severe outcome emerged. …”
  7. 19827
  8. 19828

    Expression of <i>Fgfr2</i> in E10.5 in control and <i>Fgfr2<sup>ST−/−</sup></i> embryos. by Kenneth A. Walker (280683)

    Published 2013
    “…Quantitative real-time PCR of FAC-sorted E10.5 <i>Cag-Tbx18cre<sup>Tg/+</sup></i> (Control) and <i>Cag-Fgfr2<sup>ST−/−</sup></i> (<i>Fgfr2<sup>St−/−</sup></i>) urogenital ridges confirms a dramatic decrease in <i>Fgfr2</i> mRNA expression in mutant Tbx18cre expressing cells. …”
  9. 19829
  10. 19830
  11. 19831
  12. 19832
  13. 19833
  14. 19834

    CONSORT flow diagram of the study. by Mohammad Sidiq (18625406)

    Published 2024
    “…</p><p>Findings</p><p>Post-intervention score comparisons between the groups revealed that the pain education intervention led to a significant reduction in disability compared to the usual standard care at 6 weeks (mean difference 8.2, p < 0.001, effect size Cohen d = 0.75), a decrease in pain intensity (mean difference 3.5, p < 0.001, effect size Cohen d = 0.82), and an improvement in the well-being index (mean difference 13.7, p < 0.001, effect size Cohen d = 0.58).…”
  15. 19835
  16. 19836

    Iridium(III, 0, and −I) Complexes Stabilized by 1,1‘-Bis(diphenylphosphino)ferrocene (dppf):  Synthesis and Characterization. Crystal Structures of [Na(THF)<sub>5</sub>][Ir(dppf)<s... by Bruno Longato (2315767)

    Published 1999
    “…<b>3</b> crystallizes in the triclinic system, space group <i>P</i>1̄, with <i>a</i> = 13.019(4) Å, <i>b</i> = 13.765(6) Å, <i>c</i> = 15.549(5) Å, α = 93.74(3)°, β = 90.35(3)°, γ = 92.07(3)°, <i>V</i> = 2779(2) Å<sup>3</sup>, and <i>Z</i> = 2. …”
  17. 19837
  18. 19838
  19. 19839

    Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction by Qi Wan (271320)

    Published 2024
    “…No significant difference of ECD was found in the high (2823.45 ± 274.75 cells/mm<sup>2</sup>) and super-high myopia (2856.71 ± 323.53cells/mm<sup>2</sup>) at the visit of 5 years. Compared to baseline, we observed a significant increase in IOP at the 1-week follow-up, which decreased significantly at the one-month visit. …”
  20. 19840